Allspring Global Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.3M | Buy |
447,900
+60,094
| +15% | +$7.69M | 0.1% | 255 |
|
|
2025
Q1 | $41.5M | Sell |
387,806
-92,759
| -19% | -$9.93M | 0.07% | 330 |
|
|
2024
Q4 | $66.2M | Sell |
480,565
-209,421
| -30% | -$28.9M | 0.11% | 226 |
|
|
2024
Q3 | $79.5M | Sell |
689,986
-20,614
| -3% | -$2.38M | 0.12% | 201 |
|
|
2024
Q2 | $97.8M | Buy |
710,600
+203,934
| +40% | +$28.1M | 0.16% | 146 |
|
|
2024
Q1 | $69.9M | Buy |
506,666
+96,563
| +24% | +$13.3M | 0.11% | 241 |
|
|
2023
Q4 | $54M | Buy |
410,103
+184,660
| +82% | +$24.3M | 0.09% | 292 |
|
|
2023
Q3 | $25.4M | Sell |
225,443
-144,161
| -39% | -$16.2M | 0.05% | 487 |
|
|
2023
Q2 | $34.9M | Buy |
369,604
+31,590
| +9% | +$2.98M | 0.06% | 443 |
|
|
2023
Q1 | $34.2M | Sell |
338,014
-158,179
| -32% | -$16M | 0.06% | 439 |
|
|
2022
Q4 | $59.3M | Sell |
496,193
-42,846
| -8% | -$5.12M | 0.1% | 267 |
|
|
2022
Q3 | $57.3M | Buy |
539,039
+426,675
| +380% | +$45.3M | 0.1% | 250 |
|
|
2022
Q2 | $11M | Sell |
112,364
-90,391
| -45% | -$8.81M | 0.02% | 755 |
|
|
2022
Q1 | $19M | Sell |
202,755
-2,311
| -1% | -$217K | 0.02% | 676 |
|
|
2021
Q4 | $17.5M | Buy |
+205,066
| New | +$17.5M | 0.02% | 746 |
|